|
|
|
|
Key
Multi-Events
|
|
|
04.09.2008
ROCKVILLE, MARYLAND - Rexahn Pharmaceuticals Inc., a leader in innovative therapeutics for life-threatening and life-debilitating diseases, announced that the US Patent and Trademark Office has issued a new cancer patent (US Patent 7,405,214) entitled, "Nucleoside Derivatives and Therapeutic Use Thereof," in support of the Company's continued efforts to develop superior cancer treatments.
|
04.09.2008
PORTLAND, OR - Creative Brand Communications Inc. (CBC), a full-service multi-sensory marketing and experiential brand development agency specializing in building brands for forward-thinking banks, and Market Insights, a consulting firm that creates practical and profitable growth strategies for a wide range of financial institutions throughout the United States, announced the launch of their new collaborative service, called “Own Your Market.”
|
31.08.2008
REDMOND, WASH, TOKYO - Microsoft Corp. and Nikon Corp. have signed a patent cross-licensing agreement to further the development of each company’s current and future product lines, a press release by Microsoft stated.
|
31.08.2008
LONDON - 78% of web users would think less of a brand if it allowed an ad to appear next to offensive or inappropriate content.
|
31.08.2008
NEW YORK - Pfizer Inc. announced that the Eastern Division of the High Court in Copenhagen, Denmark has ruled in the company’s favor in challenges to two of its patents covering atorvastatin, the active ingredient in Lipitor.
|
28.08.2008
CAMPBELLVILLE, CANADA - NIR Diagnostics Inc. announced in a press release that it has entered into a settlement agreement, August 20, 2008, to dismiss its remaining claims in the patent infringement action against Masimo Corporation filed in the United States District Court by Shaklee Corporation.
|
Newer << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | > >> Older
|
|

|